G1 Therapeutics, Inc. logo

G1 Therapeutics, Inc.

NASDAQ:GTHX

Overview | Financials
Company Name G1 Therapeutics, Inc.
Symbol GTHX
Currency USD
Price 7.15
Market Cap 377,221,130
Dividend Yield 0%
52-week-range 1.08 - 7.19
Industry Biotechnology
Sector Healthcare
CEO Mr. John E. Bailey Jr.
Website https://www.g1therapeutics.com

An error occurred while fetching data.

About G1 Therapeutics, Inc.

G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive

Related Stocks

XOMA Corporation logo

XOMA Corporation

XOMA

28.98 USD

Altimmune, Inc. logo

Altimmune, Inc.

ALT

7.88 USD

Kamada Ltd. logo

Kamada Ltd.

KMDA

4.23 USD

Semler Scientific, Inc. logo

Semler Scientific, Inc.

SMLR

25.92 USD

Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc.

NVCT

6.67 USD

Entrada Therapeutics, Inc. logo

Entrada Therapeutics, Inc.

TRDA

15 USD

Accuray Incorporated logo

Accuray Incorporated

ARAY

2.19 USD

Alpha Teknova, Inc. logo

Alpha Teknova, Inc.

TKNO

4.4 USD

Financials

Numbers are in millions USD

Numbers are in millions USD